2,059
Views
6
CrossRef citations to date
0
Altmetric
Reports of Presentations at the Workshop on “Naturally Occurring Infections in Non-human Primates and Immunotoxicity Implications”, Silver Spring, MD

Naturally occurring infections in non-human primates (NHP) and immunotoxicity implications: Discussion sessions

, , , , , , , , & show all
Pages 138-146 | Received 21 Dec 2009, Accepted 24 Mar 2010, Published online: 05 May 2010

References

  • Elmore, D. B., Anderson, J. H., Hird, D. W., Sanders, K. D., and Lerche, N. W. 1992. Diarrhea rates and risk factors for developing chronic diarrhea in infant and juvenile rhesus monkeys. Lab. Anim. Sci. 42:356–359.
  • Fox, J. G., Anderson, L. A., Loew, F. M., and Quimby, F. W. (Eds.). 2002. Laboratory Animal Medicine, 2nd Edition. New York: Academic Press, pp. 676–791.
  • George, J. W., and Lerche, N. W. 1990. Electrolyte abnormalities associated with diarrhea in rhesus monkeys: 100 cases (1986-1987). J. Am. Vet. Med. Assoc. 196:1654–1658.
  • Granelli-Piperno, A., Keane, M., and Steinman, R. M. 1988. Evidence that cyclosporine inhibits cell-medicated immunity primarily at the level of the T-lymphocyte rather than the accessory cell. Transplantation 46: 53S–60S.
  • Grossman, Z., Meier-Schellersheim M., Sousa, A., Victorino, R., and Paul, W. 2002. CD4+ T-cell depletion in HIV infection: Are we closer to understanding the cause? Nature Med. 8:319–323.
  • Hird, D. W., Anderson, J. H., and Bielitzki, J. T. 1984 Diarrhea in non-human primates: A survey of primate colonies for incidence rates and clinical opinion. Lab. Anim. Sci. 34:465–470.
  • Ho, S., Clipstone, N., Timmermann, L., Northrop, J., Graef, I., Fiorentino, D., Nourse, J., and Crabtree, G. R. 1996. The mechanism of action of cyclosporine A and FK506. Clin. Immunol. Immunopath. 80:S40–S45.
  • Humar, A., Gregson, D., Caliendo, A., McGeer, A., Malkan, G., Krajden, M., Corey, P., Greig, P., Walmsley, S., Levy, G., and Mazzulli, T. 1999. Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients. Transplantation 68:1305–1311.
  • Hutto, D. L. 2010. Opportunistic infections in non-human primates exposed to immunomoduatory biotherapeutics: Considerations and case examples. J. Immunotoxicol. (In Press).
  • Lerche, N. W. 2010. Simian retroviruses: Infection and disease - Implications for immunotoxicology research in primates. J. Immunotoxicol. (In Press).
  • Lerche, N. W., and Simmons, J. H. 2008. Beyond specific pathogen-free: Biology and effect of common viruses in macaques. Comp. Med. 58:8–10.
  • Limaye, A., Jerome, K. R., Kuhr, C. S., Ferrenberg, J., Huang, M., Davis, C. L., Corey, L. and Marsh, C. L. 2001. Quantitation of BK virus load in serum for the diagnosis of BK virus–associated nephropathy in renal transplant recipients. J. Infect. Dis. 183:1669–1672.
  • Mansfield, K. 2005. Development of specific pathogen free non-human primate colonies. In: The Laboratory Primate (Wolfe-Coote, S., Ed.). London: Elsevier Academic Press, pp. 229–239.
  • McCune, J.M. 2001. The dynamics of CD4+ T-cell depletion in HIV disease. Nature 410:974–979.
  • Mellors, J. W., Rinaldo Jr. C. R., Gupta, P., White, R. M., Todd, J. A., Kingsley, L. A. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 24:1167–1170.
  • Morton, W. R., Agy, M. B., Capuano, S. V., and Grant, R. F. 2008. Specific pathogen-free macaques: Definition, history and current production. ILAR J. 49:137–144.
  • NCRR-NIH. 2009. Non-human Primate Research Resources. National Center for Research Resources Fact Sheet. http://www.ncrr.nih.gov/publications/pdf/NPRR_Fact_Sheet_508.pdf.
  • Price, K. D. 2010. Bacterial infections in cynomolgus monkeys given small molecule immunomodulatory antagonists. J. Immunotoxicol. (In Press).
  • Rivailler, P., Carville, A., Kaur, A., Rao, P., Quink, C., Kutok, J. L., Westmoreland, S., Klumpp, S., Simon, M., Aster, J. C., and Wang, F. 2004. Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: An animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host. Blood 104:1482–1489.
  • Sasseville, V. G., and Mansfield, K. G. 2010. Overview of known non-human primate pathogens with potential to affect colonies used for toxicity testing. J. Immunotoxicol. (In Press).
  • Sestak, K., Merritt, C. K., Borda, J., Saylor, E., Schwamberger, S. R., Cogswell, F., Didier, E. S., Didier, P. J., Plauche, G., Bohm, R. P., Aye, P. P., Alexa, P., Ward, R. L., and Lackner, A. A. 2003. Infectious agent and immune response characteristics of chronic enterocolitis in captive rhesus macaques. Infect. Immun.71:4078–4086.
  • Shelburne, S. A., and Hamill, R. J. 2003.The immune reconstitution inflammatory syndrome (IRIS). AIDS Rev. 5:67–79.
  • Simmons, J. H. 2010. Herpesvirus infections of laboratory macaques. J. Immunotoxicol. (In Press).
  • Taylor, K. 2010. Clinical veterinarian’s perspective of non-human primate (NHP) use in drug safety studies. J. Immunotoxicol. (In Press).
  • VandeWoude, S. J., and Luzarraga, M. B. 1991. The role of Branhamella catarrhalis in the “bloody-nose syndrome” of cynomolgus macaques. Lab. Anim. Sci. 41:401–406.
  • Vickers, J. H. 1969. Diseases of primates affecting the choice of species for toxicologic studies. Ann. N. Y. Acad. Sci. 162:659–672.
  • Wagner, H. J., Wessel, M., Jabs, W., Smets, F., Fischer, L., Offner, G., and Bucsky, P.2001. Patients at risk for development of post-transplant lymphoproliferative disorder: Plasma versus peripheral blood mononuclear cells as material for quantification of Epstein-Barr viral load by using real-time quantitative polymerase chain reaction. Transplantation 72:1012–1019.
  • Watson, A., Ranchalis, J., Travis, B., McClure, J., Sutton, W., Johnson N, P. R., Hu S, L., and Haigwood, N. L. 1997. Plasma viremia in macaques infected with simian immunodeficiency virus: Plasma viral load early in infection predicts survival. J. Virol. 71:284–290.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.